Eruzun, H. (2026) “Sclerosing cholangitis associated with dabrafenib–trametinib therapy: BRAF/MEK inhibitors should be considered”, Journal of Gastrointestinal and Liver Diseases, 35(1), pp. 136–137. doi: 10.15403/jgld-6698.